Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis

Journal of Neuroimmunology

Volumn 249, Issue 1-2, 2012, Pages 27-39

  Herder, Vanessa ^a,b   Gerhauser, Ingo ^a   Klein, Stephanie Kristin ^a   Almeida, Pedro ^c   Kummerfeld, Maren ^a   Ulrich, Reiner ^a   Seehusen, Frauke ^a   Rohn, Karl ^a   Schaudien, Dirk ^a   Baumgärtner, Wolfgang ^a,b   Huehn, Jochen ^c   Beineke, Andreas ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Cerebrum; Cytokine expression; Phenotyping; Regulatory T cells; Theiler's murine encephalomyeltis virus

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; LEUKOCYTE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STRAIN DIFFERENCE; SWISS JAMES LAMBERT MOUSE; VIRAL CLEARANCE; VIRUS ENCEPHALITIS;

ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTE SUBSETS; BRAIN; CARDIOVIRUS INFECTIONS; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THEILOVIRUS;

EID: 84863476188     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.04.010     Document Type: Article

References (65)

1. Bai F., Town T., Qian F., Wang P., Kamanaka M., Connolly T.M., Gate D., Montgomery R.R., Flavell R.A., Fikrig E. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog. 2009, 5:e1000610.
2. + entry. J. Biol. Chem. 1991, 266:18119-18226.
3. Bernard C.C., De Rosbo N.K. Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol. (Napoli) 1991, 13:171-178.
4. Borrow P., Tonks P., Welsh C.J., Nash A.A. The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 1992, 73:1861-1865.
5. Bowen J.L., Olson J.K. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease. J. Immunol. 2009, 183:6971-6980.
6. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309.
7. Chang J.R., Zaczynska E., Katsetos C.D., Platsoucas C.D., Oleszak E.L. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. Virology 2000, 278:346-360.
8. Correa F., Hernangómez-Herrero M., Mestre L., Loría F., Docagne F., Guazam C. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells. Brain Behav. Immun. 2011, 25:736-749.
9. Cross A.H., Waubant E. MS and the B cell controversy. Biochim. Biophys. Acta 2011, 1812:231-238.
10. Dal Canto M.C., Melvold R.W., Kim B.S., Miller S.D. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc. Res. Tech. 1995, 32:215-229.
11. Dal Canto M.C., Kim B.S., Miller S.D., Melvold R.W. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis. Methods 1996, 10:453-461.
12. Ejrnaes M., Filippi C.M., Martinic M.M., Ling E.M., Togher L.M., Crotty S., von Herrath M.G. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006, 203:2461-2472.
13. Evangelou N., Konz D., Esiri M.M., Smith S., Palace J., Matthews P.M. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000, 123:1845-1849.
14. Fernandez M.A., Puttur F.K., Wang Y.M., Howden W., Alexander S.I., Jones C.A. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 2008, 180:1556-1564.
15. Gerhauser I., Alldinger S., Ulrich R., Baumgärtner W. Spatio-temporal expression of immediate early genes in the central nervous system of SJL/J mice. Int. J. Dev. Neurosci. 2005, 23:637-649.
16. Gerhauser I., Alldinger S., Baumgärtner W. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J. Neuroimmunol. 2007, 188:86-94.
17. Getts M.T., Richards M.H., Miller S.D. A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology 2010, 402:102-111.
18. Hansenne I., Louis C., Martens H., Dorban G., Charlet-Renard C., et al. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation. Neuroimmunomodulation 2009, 16:35-44.
19. Himeda T., Okuwa T., Muraki Y., Ohara Y. Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV). J. Neurovirol. 2010, 16:219-229.
20. Hou W., Kang H.S., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 2009, 206:313-328.
21. Jin Y.H., Kang H.S., Mohindru M., Kim B.S. Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6×SJL)F1 mice. J. Virol. 2011, 85:3033-3040.
22. Kakalacheva K., Münz C., Lünemann J.D. Viral triggers of multiple sclerosis. Biochim. Biophys. Acta 2011, 1812:132-140.
23. Kirkman N.J., Libbey J.E., Wilcox K.S., White H.S., Fujinami R.S. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 2010, 51:454-464.
24. Kreutzer M., Seehusen F., Kreutzer R., Pringproa K., Kummerfeld M., Claus P., Deschl U., Kalkul A., Beineke A., Baumgärtner W., Ulrich R. Axonopathy is associated with complex axonal transport defects in a model of multiple sclerosis. Brain Pathol. 2011, 10:1750-3639.
25. Kummerfeld M., Seehusen F., Klein S., Ulrich R., Kreutzer R., Gerhauser I., Herder V., Baumgärtner W., Beineke A. Periventricular demyelination and axonal pathology is associated with subependymal virus spread in a murine model for multiple sclerosis. Intervirology 2012, (Electronic publication ahead of print; 2012 Apr 25). 10.1159/000336563.
26. Libbey J.E., Kirkman N.J., Smith M.C., Tanaka T., Wilcox K.S., White H.S., Fujinami R.S. Seizures following picornavirus infection. Epilepsia 2008, 49:1066-1074.
27. Lipton H.L. Theiler's virus infection in mice. Unusual biphasic disease process leading to demyelination. Infect. Immun. 1975, 11:1147-1455.
28. Lipton H.L., Gonzalez-Scarano F. Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J. Infect. Dis. 1978, 137:145-151.
29. MacDonald A.J., Duffy M., Brady M.T., McKiernan S., Hall W., Hegarty J., Curry M., Mills K.H. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 2002, 185:720-727.
30. Maris C.H., Chappell C.P., Jacob J. Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol. 2007, 8:8.
31. Martinic M.M., von Herrath M.G. Novel strategies to eliminate persistent viral infections. Trends Immunol. 2008, 29:116-124.
32. McDole J.R., Danzer S.C., Pun R.Y., Chen Y., Johnson H.L., Pirko I., Johnson A.J. Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells. Am. J. Pathol. 2010, 177:1823-1833.
33. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
34. Mi W., Prentice T.W., Young C.R., Johnson R.R., Sieve A.N., Meagher M.W., Welsh C.J. Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection. J. Neuroimmunol. 2006, 178:49-61.
35. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
36. Miller S.D., Olson J.K., Croxford J.L. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection. J. Autoimmun. 2001, 16:219-227.
37. Monteyne P. Multiple sclerosis: a secretive disease. Biomed. Pharmacother. 1999, 53:341-343.
38. Monteyne P., Bureau J.F., Brahic M. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 1997, 159:163-176.
39. Monteyne P., Bihl F., Levillayer F., Brahic M., Bureau J.F. The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J. Immunol. 1999, 162:7330-7334.
40. Münz C., Lünemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat. Rev. Immunol. 2009, 9:246-258.
41. Navarrete-Talloni M.J., Kalkuhl A., Deschl U., Ulrich R., Kummerfeld M., Rohn K., Baumgärtner W., Beineke A. Transient peripheral immune response and central nervous system leaky compartmentalization in a viral model for multiple sclerosis. Brain Pathol. 2010, 20:890-901.
42. Oleszak E.L., Kuzmak J., Good R.A., Platsoucas C.D. Immunology of Theiler's murine encephalomyelitis virus infection. Immunol. Res. 1995, 14:13-33.
43. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., Platsoucas C.D. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 2004, 17:174-207.
44. Olson J.K., Miller S.D. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. J. Immunol. 2009, 182:5712-5722.
45. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic-protein epitope in multiple sclerosis. Nature 1990, 346:183-187.
46. Pachner A.R., Brady J., Narayan K. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody. J. Neuroimmunol. 2007, 190:112-120.
47. Pullen L.C., Miller S.D., Dal Canto M.C., Van der Meide P.H., Kim B.S. Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J. Neuroimmunol. 1994, 55:143-152.
48. Richards M.H., Getts M.T., Podojil J.R., Jin Y.H., Kim B.S., Miller S.D. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J. Autoimmun. 2011, 36:142-154.
49. Rodriguez M., Zoecklein L.J., Howe C.L., Pavelko K.D., Gamez J.D., Nakane S., Papke L.M. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J. Virol. 2003, 77:12252-12265.
50. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
51. Sakaguchi S. Regulatory T cells: mediating compromises between host and parasite. Nat. Immunol. 2003, 4:10-11.
52. Sato S., Reiner S.L., Jensen M.A., Roos R.P. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 1997, 76:213-223.
53. Seehusen F., Baumgärtner W. Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis. Brain Pathol. 2010, 20:551-559.
54. Sergerie Y., Rivest S., Boivin G. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J. Infect. Dis. 2007, 196:853-860.
55. Svitek N., von Messling V. Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 2007, 362:404-410.
56. Toka F.N., Suvas S., Rouse B.T. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J. Virol. 2004, 78:13082-13089.
57. Tsunoda I. Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virol. 2008, 3:579-593.
58. Tsunoda I., Fujinami R.S. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 1996, 55:673-686.
59. Ulrich R., Baumgärtner W., Gerhauser I., Seeliger F., Haist V., Deschl U., Alldinger S. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating Theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 2006, 65:783-793.
60. Ulrich R., Kalkuhl A., Deschl U., Baumgärtner W. Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. J. Cell. Mol. Med. 2010, 14:434-448.
61. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 18:3.
62. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
63. Yamada M., Zurbriggen A., Fujinami R.S. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 1990, 171:1893-1907.
64. Zelinskyy G., Dietze K., Sparwasser T., Dittmer U. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog. 2009, 5:e1000406.
65. Zoecklein L.J., Pavelko K.D., Gamez J., Papke L., McGavern D.B., Ure D.R., Njenga M.K., Johnson A.J., Nakane S., Rodriguez M. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol. 2003, 13:291-308.